Financing - June 16, 2020
New report: 35 billion SEK to Swedish life sciences in the past 5 years
The period 2015-2019 has been a busy, and expansive one for Swedish life science companies, according to data analysed by Industrifonden. Industrifonden’s just-released Life Science Report, based on fresh data and analysis examines the flows of capital to Therapeutics, Healthtech, Diagnostics, and Medtech companies from 2015 to 2019. Of the 35 billion SEK total, the […]
Collaboration - June 11, 2020
Nordic initiative offers courses in health innovation
The School of Health Innovation, founded by Karolinska Institutet, KI, Oslo University, UiO, and Norwegian University of Science and Technology NTNU, is the first Nordic initiative to offer courses in innovation as an extension of the academic subjects health sciences and life sciences. In addition, the University of Copenhagen will be joining the initiative shortly […]
In a new job - June 2, 2020
Richard Hausmann resigns as President and CEO of Elekta
Elekta has announced that Richard Hausmann, President and Chief Executive Officer, has decided to resign for personal reasons with immediate effect. “It has been a privilege to lead Elekta’s journey over the past four years, helping our customers to improve the life of millions of cancer patients around the world. I am proud to have […]
In a new job - June 2, 2020
She is the new CFO of Bactiguard
Bactiguard Holding AB (publ) has appointed Gabriella Björknert Caracciolo as new CFO and Executive Vice President. Gabriella Björknert Caracciolo is currently Head of Strategy, Development and Governance within Transaction Banking, Nordea and has been employed by the bank since 2016. Prior to that she held a number of different leading positions within Skandinaviska Enskilda Banken […]
Financing - June 1, 2020
“Aim high and build a strong team”
Jonas Jendi is an Investment Manager within the life science sector at Industrifonden, an evergreen venture capital fund, based in Stockholm, focusing on early-stage companies within life science and technology. In the current life science portfolio he is responsible for Nuevolution, Smartfish and Airsonett. What kind of companies are you and your colleagues focusing your […]
Clinical Trials - May 15, 2020
Gesynta Pharma announces positive trial results
Gesynta Pharma has reported positive Phase I results with GS-248 for the treatment of microvascular disease. The Phase I study was designed to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of single oral doses up to 300 mg and multiple once daily doses up to 180 mg for 10 days in healthy male and female […]
